Skip to main content

Federal Judge Rejects Sanofi's Bid In Taxotere MDL

Federal Judge Rejects Sanofi's Bid In Taxotere MDL

Federal Judge Rejects Sanofi's Bid In Taxotere MDL

Introduction

Sanofi's bid for summary judgment in the second bellwether case of Taxotere in multidistrict litigation has been rejected by a federal judge.

The lawsuit alleges that the plaintiff suffered from permanent hair loss due to the usage of Sanofi's drug Taxotere. The attorneys representing the company are not happy with the ruling and stated that they would take the court's decision sportingly and keep the documents and facts in front of the jury to prove that Sanofi is not responsible for the plaintiff's hair loss. The trial of the plaintiff's lawsuit will begin on August 23, 2021.

The company's attorneys stated that as per the "learned intermediary" doctrine of Louisiana, the drugmaker needs to warn the doctors and not the patients. Hence, the drugmaker is not at fault as even the doctor mentioned that he would have prescribed the drug even after the label warning on the product.

The company even raised a motion in the 5th Circuit U.S. Court of Appeals in another case of the MDL. The plaintiff in the lawsuit completely believed in the doctor and did not ask for any other options apart from Taxotere.

Currently, Sanofi faces 12,000 product liability cases that allege the company of distributing and manufacturing Taxotere, a chemotherapy drug linked to permanent hair loss among the users. The company even faces lawsuits in different state courts across the U.S., including New Jersey, California, and Delaware. 

The U.S. Food and Drug Administration (FDA) approved Taxotere in 1996. Judge Kurt D. Engelhardt is overlooking the Taxotere lawsuits, which are consolidated under MDL No. 2740 IN RE: Taxotere (Docetaxel) Products Liability Litigation in U.S. District Court for the Eastern District of Louisiana.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!